These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26343269)

  • 1. Determination of suvorexant in human plasma using 96-well liquid-liquid extraction and HPLC with tandem mass spectrometric detection.
    Breidinger SA; Simpson RC; Mangin E; Woolf EJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Oct; 1002():254-9. PubMed ID: 26343269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of the HIV integrase inhibitor, MK-0518 (raltegravir), in human plasma using 96-well liquid-liquid extraction and HPLC-MS/MS.
    Merschman SA; Vallano PT; Wenning LA; Matuszewski BK; Woolf EJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Sep; 857(1):15-24. PubMed ID: 17644453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simple and Highly Sensitive UPLC-ESI-MS/MS Assay for Rapid Determination of Suvorexant in Plasma.
    Iqbal M; Ezzeldin E; Khalil NY; Al-Rashood ST; Al-Rashood KA
    J Anal Toxicol; 2017 Mar; 41(2):114-120. PubMed ID: 28376227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development and validation of a selective and robust LC-MS/MS method for high-throughput quantifying rizatriptan in small plasma samples: application to a clinical pharmacokinetic study.
    Chen Y; Miao H; Lin M; Fan G; Hong Z; Wu H; Wu Y
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Dec; 844(2):268-77. PubMed ID: 16899417
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liquid chromatographic-electrospray tandem mass spectrometric determination of clarithromycin in human plasma.
    Li W; Rettig J; Jiang X; Francisco DT; Naidong W
    Biomed Chromatogr; 2006 Nov; 20(11):1242-51. PubMed ID: 16838265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Suvorexant in Blood Using LC-MS-MS: Important Considerations for Matrix Effects and Quantitative Interferences in Targeted Assays.
    Skillman B; Kerrigan S
    J Anal Toxicol; 2020 Apr; 44(3):245-255. PubMed ID: 31788700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A flexible and high throughput liquid chromatography-tandem mass spectrometric assay for the quantitation of telcagepant in human plasma.
    Du L; Miller-Stein CM; Valesky RJ; Martucci AN; Woolf EJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 May; 877(14-15):1465-71. PubMed ID: 19346171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validated UPLC-MS/MS method for quantification of melatonin receptor agonists and dual orexin receptor antagonists in human plasma and breast milk: Application to quantify suvorexant and lemborexant in clinical samples.
    Ishikawa H; Furugen A; Nishimura A; Umazume T; Ishikawa S; Aoyagi R; Narumi K; Okamoto K; Takekuma Y; Sugawara M; Kobayashi M
    J Pharm Biomed Anal; 2024 Dec; 251():116432. PubMed ID: 39180895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of suvorexant in blood using liquid chromatography-quadrupole/time of flight (LC-Q/TOF) mass spectrometry.
    Skillman B; Kerrigan S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Aug; 1091():87-95. PubMed ID: 29859493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and validation of a selective and sensitive bioanalytical procedure for the quantitative determination of gaboxadol in human plasma employing mixed mode solid phase extraction and hydrophilic interaction liquid chromatography with tandem mass spectroscopic detection.
    Kall MA; Fu I; Dige T; Vallano P; Woolf E; Jørgensen M
    J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Oct; 858(1-2):168-76. PubMed ID: 17851145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantification of suvorexant in urine using gas chromatography/mass spectrometry.
    Carson M; Kerrigan S
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():289-294. PubMed ID: 27825624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Simultaneous determination of a novel KDR kinase inhibitor and its N-oxide metabolite in human plasma using 96-well solid-phase extraction and liquid chromatography/tandem mass spectrometry.
    Xu Y; Du L; Soli ED; Braun MP; Dean DC; Musson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Mar; 817(2):287-96. PubMed ID: 15686997
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A UHPLC-MS/MS bioanalytical assay for the determination of BMS-911543, a JAK2 inhibitor, in human plasma.
    Liu J; Yuan L; Liu G; Shen JX; Aubry AF; Arnold ME; Ji QC
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Jun; 991():85-91. PubMed ID: 25930207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UPLC-MS/MS determination of suvorexant in urine by a simplified dispersive liquid-liquid micro-extraction followed by ultrasound assisted back extraction from solidified floating organic droplets.
    Iqbal M; Ezzeldin E; Khalil NY; Alam P; Al-Rashood KA
    J Pharm Biomed Anal; 2019 Feb; 164():1-8. PubMed ID: 30339947
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative high-throughput determination of endogenous retinoids in human plasma using triple-stage liquid chromatography/tandem mass spectrometry.
    Gundersen TE; Bastani NE; Blomhoff R
    Rapid Commun Mass Spectrom; 2007; 21(7):1176-86. PubMed ID: 17330217
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative determination of odanacatib in human plasma using liquid-liquid extraction followed by liquid chromatography-tandem mass spectrometry analysis.
    Sun L; Forni S; Schwartz MS; Breidinger S; Woolf EJ
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Feb; 885-886():15-23. PubMed ID: 22230741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strategies on efficient method development of on-line extraction assays for determination of MK-0974 in human plasma and urine using turbulent-flow chromatography and tandem mass spectrometry.
    Xu Y; Willson KJ; Musson DG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Feb; 863(1):64-73. PubMed ID: 18255359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous analysis of oxybutynin and its active metabolite N-desethyl oxybutynin in human plasma by stable isotope dilution LC-MS/MS to support a bioequivalence study.
    Sharma P; Patel DP; Sanyal M; Berawala H; Guttikar S; Shrivastav PS
    J Pharm Biomed Anal; 2013 Oct; 84():244-55. PubMed ID: 23867086
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Automated 96-well solid phase extraction and hydrophilic interaction liquid chromatography-tandem mass spectrometric method for the analysis of cetirizine (ZYRTEC) in human plasma--with emphasis on method ruggedness.
    Song Q; Junga H; Tang Y; Li AC; Addison T; McCort-Tipton M; Beato B; Naidong W
    J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(1):105-14. PubMed ID: 15607714
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Suvorexant in Urine Using Liquid Chromatography-Quadrupole/Time-of-Flight Mass Spectrometry (LC-Q/TOF-MS).
    Sullinger S; Bryand K; Kerrigan S
    J Anal Toxicol; 2017 Apr; 41(3):224-229. PubMed ID: 28035034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.